Quick answers

What is AOD-9604 and what is it used for in research?
AOD-9604 is classified within the Body Recomposition group. 16-amino-acid fragment of hGH. Preclinical data suggests selective lipolysis without affecting IGF-1. Research applications focus on the pathways outlined below. All references on this page describe published research only, AOD-9604 is supplied for in-vitro and laboratory use, not for human consumption.
How does AOD-9604 work?
Primary mechanism: C-terminal fragment of hGH (176–191); investigated for lipolytic activity. Downstream effects depend on dose, timing, and the biological system under investigation. Receptor binding and post-receptor signalling for AOD-9604 remain areas of active study, and several proposed effects are supported only by preclinical data.
What is the typical AOD-9604 research dose?
Published research protocols for AOD-9604 describe per-dose ranges of 300 mcg / day, with a weekly total near 1.5–2 mg, administered daily sc (fasted). Typical cycle: 12 weeks on / 4 off. These ranges reflect the literature and are not dosing recommendations for any individual.
Where can I buy AOD-9604 in Thailand?
AOD-9604 is supplied by Thailand Peptides, a Bangkok-based research-peptide supplier. Orders are placed directly via WhatsApp to the Bangkok research desk, no cart, no account, no forms. Pricing and shipping are provided on request. Open a line with the research desk →
How fast can AOD-9604 be delivered in Thailand?
Same-week delivery across Thailand is standard for orders confirmed within business hours (GMT+7, Monday–Saturday). Bangkok metro deliveries typically arrive within 1–3 business days; other provinces within 3–5. Regional Southeast Asia shipping is available on request.

What is AOD-9604?

AOD-9604 is a research peptide in the Body Recomposition class. C-terminal fragment of hGH (176–191); investigated for lipolytic activity. It is studied at per-dose ranges of 300 mcg / day (1.5–2 mg weekly), administered daily sc (fasted) over cycles of 12 weeks on / 4 off. Supplied in Thailand by Thailand Peptides, Bangkok-based, research use only.

16-amino-acid fragment of hGH. Preclinical data suggests selective lipolysis without affecting IGF-1.

Published and preclinical data are summarised below; dose ranges shown reflect protocols in the research literature and should be interpreted accordingly.

How does AOD-9604 work?

AOD-9604 is a synthetic analogue of the C-terminal residues 176–191 of human growth hormone. In preclinical models it produces lipolytic activity and reduces adipose tissue in obese rodents without the IGF-1 elevation, insulin-sensitivity changes, or tissue growth associated with full-length hGH. The lipolytic pathway appears to act independently of classical β-adrenergic receptors in several published studies.

Receptor binding affinity and post-receptor signalling for AOD-9604 remain areas of active investigation; several proposed effects within the Body Recomposition class are currently supported only by in-vitro or rodent data, and should be interpreted accordingly.

AOD-9604 pharmacokinetics

Half-life
Short systemic half-life after SC dosing; oral bioavailability is low in published work.
Bioavailability
SC route is standard in research; oral formulations explored but with limited absorption.
Route of administration
Subcutaneous injection, typically once daily in a fasted state in research protocols.
Metabolic clearance
Proteolytic clearance of the 16-aa fragment; no accumulation reported.

AOD-9604 research timeline

  1. 2001 Heffernan et al., hGH fragment AOD9604 lipolytic mechanism in mouse adipocytes (Endocrinology).

AOD-9604 dosage & protocol

Reference protocol for AOD-9604 (research context only, drawn from published literature):

  • Per dose: 300 mcg / day
  • Weekly total: 1.5–2 mg
  • Frequency: Daily SC (fasted)
  • Cycle: 12 weeks on / 4 off

AOD-9604 injection & handling

Reconstitution
Typical research prep: 5 mg vial + 2 mL bacteriostatic water, yielding 2.5 mg/mL.
Storage
Lyophilised powder at −20 °C; reconstituted solution refrigerated for up to 4 weeks in research protocols.
Sites used in the research literature
Subcutaneous abdomen on an empty stomach per published protocols.

Handling notes reflect methods used in published research protocols, not medical dosing guidance.

Order AOD-9604
Ready to order? WhatsApp the Bangkok research desk, pricing and availability confirmed within the chat.
Ask about AOD-9604 ≥98% HPLC purity · supplier COA on file · Bangkok-based

Stacking AOD-9604

Commonly referenced pairing with AOD-9604: GHRH analog. Stacking rationale should be grounded in complementary mechanisms, not additive speculation; interactions at shared receptors or enzymatic pathways should be accounted for. Both compounds in a AOD-9604 stack are supplied by Thailand Peptides on the same order via the Bangkok research desk.

Contraindications

Active malignancy. Additional caution is warranted in individuals with hepatic or renal impairment, endocrine disorders, or concurrent pharmacotherapy affecting the pathways described above.

Further reading

Compare AOD-9604 with: 5-Amino-1MQ

Citations

  1. Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice. Endocrinology. 2001. PMID: 11713213

References curated from PubMed. Additional literature summarised in the Thailand Peptides research library.